The startup intends to regrow human livers, which might revolutionize organ donation.
LyGenesis and iTolerance appear to be ready to save people with fatal liver disorders who are not transplant candidates.
According to MIT Technology Review, a volunteer in Boston, Massachusetts, will be the first to attempt a novel procedure that could result in the creation of a second liver in their body in the coming weeks.
The primary development asset of LyGenesis is a liver regeneration study detailed in Liver Transportation, which was carried out by Paulo Fontes et al.
The company's goal is to inject donor liver cells into the lymph nodes of sick patients. This might result in the protrusion of small organs in the body. These mini-livers are supposed to compensate for those that are worthless.
When tested on mice and pigs, the study was deemed a success. Time will tell whe...